Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
MedArrive
AddedFeb 15, 2024
UpdatedJun 18, 2026
MedArrive

MedArrive

Series A

MedArrive connects EMS professionals to patients at home, providing accessible, cost-effective healthcare via a holistic care platform.

HQ
New York City, NY, US
Founded
2020
Overview
Compare
Fundraising
Employees
Website

MedArrive was founded with the mission to bring more humanity to healthcare by bridging the virtual care gap and providing hands-on care at home. The company offers a care management platform that connects EMS professionals with patients in their homes, enabling healthcare providers to deliver high-quality, cost-effective services. MedArrive's holistic care model focuses on serving vulnerable populations, fostering patient self-advocacy, and reducing overall healthcare costs.

Notable affiliated people include experienced healthcare professionals and technologists who have contributed to the development of the platform. The company has attracted significant investment from leading venture capital firms, which has fueled its growth and expansion. Key achievements include successfully integrating a network of highly trained field providers and establishing partnerships with health plans and healthcare providers. MedArrive has made a substantial impact by improving access to healthcare and promoting health equity for underserved communities.

MedArrive - Quick Facts

When was MedArrive founded?

MedArrive was founded in 2020.

Where is MedArrive's headquarters located?

MedArrive's headquarters is located in New York City, NY, US.

When was MedArrive's last funding round?

MedArrive's most recent funding round was for $8M (USD) in April 2023.

How much has MedArrive raised to-date?

As of Apr 11, 2023, MedArrive has raised a total of $70.3M (USD).

How many employees does MedArrive have?

MedArrive has 44 employees as of Feb 5, 2024.

MedArrive - Classification

Ownership
  • Equity
  • Venture Capital
Technology
  • Analytics
Geographic Exposure
  • United States
Model
  • Platform
Revenue
  • Recurring
  • Software
  • Transactional
Customer
  • Enterprise
Main Product
  • Healthcare
  • Telemedicine
Tags
  • Healthtech
  • SaaS
NAICS
  • 621000Ambulatory Health Care Services
  • 621600Home Health Care Services
  • 621610Home Health Care Services
  • 620000Health Care and Social Assistance
SIC
  • 8080Home Health Care Services
  • 8082Home Health Care Services
  • 8000Health Services
Show 7 more industry codes
NAICS
  • 622000Hospitals
  • 622100General Medical and Surgical Hospitals
  • 622110General Medical and Surgical Hospitals
  • 623000Nursing and Residential Care Facilities
SIC
  • 8060Hospitals
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified